Close
Patheon
Biopharma Advances Demand Specialized Expertise
Biologics
Author: Scott Lorimer
Sunday, September 20, 2015

Scott Lorimer, vice president of global operations at Patheon Biologics shares insights on biopharma market developments and the implications of biosimilar drug approvals in an article "Biopharma Advances Demand Specialized Expertise" published by 'BioPharm International'. 

 

Please complete the short form below to download this whitepaper.

Connect

We look forward to learning about your specific needs, please contact us.